We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Study Explains How Protein Complex Mediates T-cell Development

By Gerald M. Slutzky, PhD
Posted on 30 Nov 2016
Print article
Image: A micrograph of cells in the thymus, an organ located just above the heart that trains immune T-cells to defend the body against viruses and bacteria (Photo courtesy of the Walter and Eliza Hall Institute).
Image: A micrograph of cells in the thymus, an organ located just above the heart that trains immune T-cells to defend the body against viruses and bacteria (Photo courtesy of the Walter and Eliza Hall Institute).
A recent paper extended our understanding of how T-cells develop into critical components of the immune system that are able to fight off pathogens without going out of control and triggering an autoimmune response.

The linear ubiquitin chain assembly complex (LUBAC) is a protein complex that is essential for innate immunity in mice and humans, yet its role in adaptive immunity is unclear. In an effort to better define the role of LUBAC, investigators at the Walter and Eliza Hall Institute (Melbourne, Australia) examined the requirement for each LUBAC component in T-cell and regulatory T-cell (Treg) cell lineages.

Results published in the November 18, 2016, online edition of the journal Nature Communications revealed that LUBAC components HOIP, HOIL-1, and SHARPIN played pivotal roles in late thymocyte differentiation of conventional T-cells, non-conventional T-cells and Treg cell homeostasis. LUBAC activity was necessary for the transcriptional programming of late thymocyte differentiation. LUBAC activity was not required to prevent TNF (tumor necrosis factor)-induced apoptosis or necroptosis but was necessary for the transcriptional program of the final stages of thymocyte differentiation.

"Another interesting aspect of this research relates to rare inherited immune disorders caused by defects in the genes that encode the components of LUBAC," said senior author Dr. Daniel Gray. "Our research has provided new insights into how these disorders are linked to faulty T-cell function. This may inspire to new immune-based therapies for these conditions. We hope that by understanding this process better, we may be able to develop new approaches to "switch off" autoimmune T-cells. This may have therapeutic applications in the future for treating autoimmune diseases."

Related Links:
Walter and Eliza Hall Institute

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
FLU/RSV Test
Humasis FLU/RSV Combo
New
Lab Sample Rotator
H5600 Revolver

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.